Physician profile
Darwana Todd
NPI 1851360655
$1,232.69
in general payments reported to CMS, 2019-2025
15 companies · $34.87 in 2025
The $34.87 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2022: $654 · 2023: $33.26 · 2024: $14.54 · 2025: $34.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $520.53 | 2022 | |
| Abbvie INC. | $124.11 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $121.87 | 2019 | |
| Avanos Medical | $64.97 | 2019 | |
| Minerva Surgical, INC | $61.03 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.04 | 2019 | |
| Organon LLC | $57.70 | 2022-2025 | Nexplanon |
| Therapeuticsmd, INC. | $44.49 | 2019 | |
| Coopersurgical, INC. | $36.29 | 2019 | |
| Convatec INC. | $35.79 | 2022 | |
| Medtronic, INC. | $32.38 | 2022-2023 | Endurant Iis |
| Amag Pharmaceuticals, INC. | $30.82 | 2019 | |
| Allergan, INC. | $16.68 | 2019 | |
| Aspira Women'S Health INC | $14.54 | 2024 | Ova1 |
| Ethicon US, LLC | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darwana Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.